Details for New Drug Application (NDA): 207777
✉ Email this page to a colleague
NDA 207777 describes APREPITANT, which is a drug marketed by Glenmark Speclt, Sandoz, Torrent, Azurity, and Mylan, and is included in five NDAs. It is available from five suppliers. Additional details are available on the APREPITANT profile page.
The generic ingredient in APREPITANT is aprepitant. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the aprepitant profile page.
The generic ingredient in APREPITANT is aprepitant. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the aprepitant profile page.
Summary for 207777
| Tradename: | APREPITANT |
| Applicant: | Glenmark Speclt |
| Ingredient: | aprepitant |
| Patents: | 0 |
Suppliers and Packaging for NDA: 207777
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| APREPITANT | aprepitant | CAPSULE;ORAL | 207777 | ANDA | BluePoint Laboratories | 68001-666 | 68001-666-01 | 1 BLISTER PACK in 1 CARTON (68001-666-01) / 1 CAPSULE in 1 BLISTER PACK |
| APREPITANT | aprepitant | CAPSULE;ORAL | 207777 | ANDA | BluePoint Laboratories | 68001-666 | 68001-666-17 | 5 BLISTER PACK in 1 CARTON (68001-666-17) / 1 CAPSULE in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 40MG | ||||
| Approval Date: | Oct 12, 2017 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 80MG | ||||
| Approval Date: | Oct 12, 2017 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 125MG | ||||
| Approval Date: | Oct 12, 2017 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
